📊 Get daily AI-graded market briefings
Morning + evening · AI impact + sector exposure · Free
LAST 30 DAYS
6 articles
AVG GRADE
NEUTRAL
score: 0.33
SENTIMENT
NEUTRAL
TOTAL VIEWS
17
PHAR Stock Analysis & AI Grade: NEUTRAL
6 articles analyzed · Sentiment: NEUTRAL · AI-powered equity research
RECENT COVERAGE · 6 ARTICLES
Pharming Group to participate in Canaccord Genuity 46th Annual Growth Conference
PHAR (Pharming Group N.V.) announced participation in the Canaccord Genuity 46th Annual Growth Conference scheduled for August 12-13,...
Pharming Group N.V. (PHAR) Q2 2026 Earnings Call Transcript
Pharming Group N.V. (PHAR) released Q2 2026 earnings via earnings call, a routine disclosure event for a specialized biopharmaceutical...
Pharming Group Q2 Earnings Call Highlights
Pharming Group (PHAR) reported Q2 revenue of $90.2 million, representing a 3% year-over-year decline despite offsetting contributions...
Pharming Group N.V. 2026 Q2 - Results - Earnings Call Presentation (NASDAQ:PHAR) 2026-07-30
Pharming Group N.V. (NASDAQ: PHAR) released its Q2 2026 earnings presentation, a routine corporate disclosure event that provides...
Pharming Group to report second quarter and first half 2026 financial results and provide business update on July 30
Pharming Group announced a scheduled earnings release and business update for Thursday, July 30, 2026, covering second quarter and...
Form 8.5 (EPT/RI) - Pharos Energy Plc
This filing represents a Form 8.5 disclosure under UK Takeover Code Rule 8.5, documenting dealings by an exempt principal trader acting...
E
ESEN Analytics
AI-powered equity research platform covering 5,000+ US equities. Our proprietary AI grading system (A+ to D scale) analyzes fundamentals, technicals, and news sentiment daily. Coverage data updated every 24 hours.
Learn about our methodology →
ⓘ AI-graded news coverage · Not investment advice